logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
25/07/2025
New Zealand Reserve Bank Chief Economist: The uncertainty about tariffs may reduce New Zealand's business investment and inflation.
Latest
3 m ago
Powell vows to complete his term as Federal Reserve chairman.
6 m ago
Thailand has announced the imposition of martial law in certain areas bordering Cambodia.
7 m ago
Shenghualand Holdings Limited (08106.HK) controlling shareholder plans to change hands and will receive approximately 20.20% of the full acquisition offer from Shanghai Xinhua and Cloud Odd. The resumption of trading will take place on July 28th.
9 m ago
U.S. stock market anomaly | Linkhome (LHAI.US), a newly listed stock, once rose nearly 130% and triggered another trading halt.
10 m ago
Medical research and drug development company Sarepta Therapeutics Inc. fell by more than 13.66% at one point, leading to a cumulative decline of over 20.96% in the past five trading days. An advisory committee of the European Medicines Agency has recommended against approving the company's gene therapy Elevidys.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.